Formulations for reducing anxiety in non-human mammals by increasing brain serotonin levels
AssigneeNorth Cell Pharmaceuticals Inc.
InventorAlain Martin
Life of this patent
Estimating the term…
Loading patent…
AssigneeNorth Cell Pharmaceuticals Inc.
InventorAlain Martin
Estimating the term…
A method of reducing anxiety in a non-human mammal by increasing brain serotonin levels, includes: down regulating in vivo levels of indigenous inflammatory cytokines in the nasal cavity of said non-human mammal by delivering an effective amount of an anti-inflammatory formula to said nasal cavity, which formula includes: at least one lipid-soluble antioxidant (which also functions as an anti-inflammatory agent) (the lipid-soluble antioxidant may be selected from the group consisting of alpha lipoic acid, aloe vera, omega 3 oil, N-acetylcysteine, cannabidiol, civet, oxytocin and combinations thereof); melatonin; tryptophan; and at least one essential oil. The most preferred antioxidant is N-acetylcysteine and the preferred essential oil is combination of chamomile, lavender and lemon oil.
Formulations for use in methods of reducing anxiety in a non-human mammal by increasing brain serotonin levels, which comprises:
Dependencies are inferred from the claim text.